2012
DOI: 10.1007/s10847-012-0222-9
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization and sustaining controlled release effect of mesoporous SBA-15/ramipril composite drug

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 23 publications
1
8
0
Order By: Relevance
“…1. By observing the XRD diffraction peaks of the sample, it is found that these peaks are in good agreement with those reported in the literature (Zhai et al 2013) and have the typical characteristic peaks of SBA-15. Therefore, the prepared sample is SBA-15.…”
Section: Sample Characterizationsupporting
confidence: 87%
See 2 more Smart Citations
“…1. By observing the XRD diffraction peaks of the sample, it is found that these peaks are in good agreement with those reported in the literature (Zhai et al 2013) and have the typical characteristic peaks of SBA-15. Therefore, the prepared sample is SBA-15.…”
Section: Sample Characterizationsupporting
confidence: 87%
“…After it, cooling, washing, filtering and room temperature drying were carried on, white powder was obtained and calcined at 550 °C for 24 h in a muffle furnace. After the template was removed successfully, white powder SBA-15 mesoporous molecular sieve was obtained (Zhai et al 2013).…”
Section: Preparation Of Sba-15mentioning
confidence: 99%
See 1 more Smart Citation
“…In this regard, 70-95% of the hydrophobic drug Dasatinib, loaded in SBA-15 was released in just 2 h, independent of the porosity of the materials [44]. A controlled release was obtained by Qing-Zhou et al [45] with Ramipril, also a hydrophobic drug, having about 50% of the drug released after 5 h. Shahriarinour et al [46] found a THY release of about 6.8% during the first hour and the release increased to 95.1% after 4 days. The sustained release achieved in our loaded materials could be related to the amphipathic behaviour of THY resulting from the analysis of its chemical structure [47].…”
Section: Thy/sba-15 Loaded Pcl Fibersmentioning
confidence: 85%
“…Pioneering work in use of periodic nanoporous silica nanoparticles for drug delivery was done by M. Valet Regí et al They studied the use of MCM-41 silica for controlled release of ibuprofen and the influence of surface morphology and its modification by amines to the release of the drug [14][15][16][17][18][19][20]. These works started intensive research and different drugs including antibiotics [21], drugs regulating blood circulatory disorders in the brain [22], antihypertensive drugs [23], anticancer drugs [24], antiviral drugs [25], vitamins [26], chemopreventive agents [27], antibacterial agents [28][29][30], non-steroidal anti-inflammatory drugs [31,32] were studied. In most of the studies silica with unidirectional channels of hexagonal 2D structure (MCM-41, SBA-15) was investigated.…”
Section: Introductionmentioning
confidence: 99%